Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 1c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of $0.19, $0.01 better than the analyst estimate of $0.18. Revenue for the quarter came in at $21.3 million versus the consensus estimate of $21.96 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker